Implications for immunotherapy of tumor-mediated T-cell apoptosis associated with loss of the tumor suppressor PTEN in glioblastoma
- 1 December 2010
- journal article
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 17 (12) , 1543-1547
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Honokiol-mediated Inhibition of PI3K/mTOR PathwayJournal of Immunotherapy, 2009
- Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in gliomaNature Medicine, 2006
- Costimulatory molecule B7‐H1 in primary and metastatic clear cell renal cell carcinomaCancer, 2005
- B7-homolog 1 expression by human glioma: a new mechanism of immune evasionNeuroReport, 2005
- In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysisBlood, 2004
- Modulation of major histocompatibility complex Class I molecules and major histocompatibility complex—bound immunogenic peptides induced by interferon-α and interferon-γ treatment of human glioblastoma multiformeJournal of Neurosurgery, 2004
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasionNature Medicine, 2002
- Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN‐γ‐inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4+ T‐cell activationGlia, 2001
- The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-?, T-cell apoptosis, and the immune privilege of the brainBrain Research Reviews, 1995